FORAY bioscience, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
FORAY bioscience, Inc. - overview
Established
2022
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2022 by Ashley Beckwith, FORAY Bioscience, Inc. , a. k. a.
Foray Bioscience operates as a biotechnology company that focuses on biomanufacturing tree and plant products for supply and to prevent deforestation. In February 2024, FORAY Bioscience, Inc. raised USD 3. 41 million in venture funding.
The round was part of a larger USD 3. 91 million venture fund. Foray is developing a platform to bioengineer an expansive range of plant-based products by combining plant cell culture, materials science, and tissue engineering to provide sustainable alternatives to traditional wood products and help prevent deforestation.
Current Investors
Engine Ventures, Susquehanna Private Capital, ReGen Ventures
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Green IT, Environmental Services
Website
www.foraybio.com
Verticals
Clean Technology
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.